Evidence map›Paper›PMID 42318553›Full record

ArticleMethodsX2026

A practical approach to a single-chain variable fragment (scFv) biotinylating for immunohistochemical analysis.

Cynthia Rodríguez-Nava, Carlos Ortuño-Pineda, Amalia Vences-Velázquez, Berenice Illades-Aguiar, Karen Cortés-Sarabia, Luz Del Carmen Alarcón-Romero

Abstract read
In one paragraph

Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cynthia Rodríguez-NavaLaboratorio de Investigación en Citopatología e Histoquímica, Universidad Autónoma de Guerrero, Chilpancingo Guerrero, Mexico.
Carlos Ortuño-PinedaLaboratorio de Ácidos Nucleicos y Proteínas, Universidad Autónoma de Guerrero, Chilpancingo Guerrero, Mexico.
Amalia Vences-VelázquezLaboratorio de Investigación en Inmunobiología y Diagnóstico Molecular, Universidad Autónoma de Guerrero, Chilpancingo Guerrero, Mexico.
Berenice Illades-AguiarLaboratorio de Investigación en Biomedicina Molecular, Universidad Autónoma de Guerrero, Chilpancingo Guerrero, Mexico.
Karen Cortés-SarabiaLaboratorio de Investigación en Inmunobiología y Diagnóstico Molecular, Universidad Autónoma de Guerrero, Chilpancingo Guerrero, Mexico.
Luz Del Carmen Alarcón-RomeroLaboratorio de Investigación en Citopatología e Histoquímica, Universidad Autónoma de Guerrero, Chilpancingo Guerrero, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunohistochemistry (IHC) is a widely used technique for detecting proteins in tissue sections; however, its performance is significantly influenced by the quality of antibodies and detection strategies. Conventional IgG or IgM-based antibodies often come with high production costs, variability between batches, and limited penetration into tissues, which can compromise the uniformity and reproducibility of staining. Recombinant single-chain variable fragments (scFvs) offer an attractive alternative due to their smaller size, defined molecular composition, and renewable production capabilities. In this work, we focus on optimizing IHC by chemically biotinylating scFvs, allowing for direct coupling to streptavidin-based detection systems. This method enhances signal sensitivity while eliminating the need for secondary antibodies or additional labeling steps. Biotinylated scFvs can diffuse more easily into tissue sections, streamline the staining workflow, and reduce both assay time and cost. Overall, integrating biotinylated scFvs into IHC protocols presents a robust, scalable, and reproducible strategy that addresses key limitations of conventional antibody-based methods, thus supporting more consistent and efficient protein detection in histological analyses.This protocol allowed the optimization of conventional IHC conditions by using biotinylating scFv to achieve precise, time and cost-efficient antigen visualization.

Indexed as

BiotinylationImmunohistochemistrySingle-chain variable fragment (scFv)

Identifiers

PMID42318553
PMCPMC13273221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.